Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001776985-22-000012
Filing Date
2022-02-16
Accepted
2022-02-16 09:00:19
Documents
19
Period of Report
2022-02-16

Document Format Files

Seq Description Document Type Size
1 6-K form6-kbiontainerpressconf.htm 6-K 15144
2 EX-99.1 ex991biontainerannouncemen.htm EX-99.1 28885
3 EX-99.2 biontechpressconferencep.htm EX-99.2 14017
4 GRAPHIC biontechpressconferencep001.jpg GRAPHIC 52886
5 GRAPHIC biontechpressconferencep002.jpg GRAPHIC 188877
6 GRAPHIC biontechpressconferencep003.jpg GRAPHIC 75834
7 GRAPHIC biontechpressconferencep004.jpg GRAPHIC 108288
8 GRAPHIC biontechpressconferencep005.jpg GRAPHIC 44936
9 GRAPHIC biontechpressconferencep006.jpg GRAPHIC 122545
10 GRAPHIC biontechpressconferencep007.jpg GRAPHIC 92922
11 GRAPHIC biontechpressconferencep008.jpg GRAPHIC 90999
12 GRAPHIC biontechpressconferencep009.jpg GRAPHIC 94419
13 GRAPHIC biontechpressconferencep010.jpg GRAPHIC 140236
14 GRAPHIC biontechpressconferencep011.jpg GRAPHIC 121500
15 GRAPHIC biontechpressconferencep012.jpg GRAPHIC 123543
16 GRAPHIC biontechpressconferencep013.jpg GRAPHIC 117126
17 GRAPHIC biontechpressconferencep014.jpg GRAPHIC 113431
18 GRAPHIC biontechpressconferencep015.jpg GRAPHIC 25460
19 image_0a.jpg GRAPHIC 25832
  Complete submission text file 0001776985-22-000012.txt   2180531
Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190847081
BioNTech SE (Filer) CIK: 0001776985 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39081 | Film No.: 22641629
SIC: 2836 Biological Products, (No Diagnostic Substances)